‘This is the mental health moment’: Innovation and M&A are helping to boost these stocks to new heights
Two recent M&A announcements by big pharma are creating excitement among investors. Here's who is poised to benefit. Source link
Read More
Karuna Therapeutics Inc
Bristol-Myers CEO talks new acquisitions: ‘We are writing the next chapter of this company’
Bristol-Myers Squibb CEO Chris Boerner detailed the pharmaceutical giant's slew of recent acquisitions in a Monday interview with CNBC's Jim
Read More
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. A look at what 2024 might
Read More
Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push
Bristol Myers Squibb said on Tuesday it would buy RayzeBio for about $4.1 billion to bolster its cancer drug business.
Read More
Stocks making the biggest moves midday: Nike, Rocket Lab, Bristol Myers, NetEase and more
These are the stocks posting the largest moves in midday trading. Source link
Read More
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
Bristol Myers Squibb said it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash. Source link
Read More
Analysts love these AI stocks with big upside potential to play the ChatGPT-driven artificial intelligence craze
With the current hype around ChatGPT, investors need to be able to distinguish an exciting AI opportunity from an overhyped
Read More
Citi names its top biotech stock picks for 2023 — and gives one 73% upside
Biotech has been a "stock-pickers market" — and it may have just what it takes to remain one in 2023,
Read More